Invited Commentary  May 17, 2023 Increasing Funding for Surgeon-Scientists—Lowering the Bar Is Not the Answer Katherine A. Gallagher, Justin B. Dimick JAMA Surg. 2023;158(7):765. doi:10.1001/jamasurg.2023.1580 In this issue of JAMA Surgery, Nguyen et al1 conducted a rigorous evaluation of National Institutes of Health (NIH) funding among surgical departments. They found that, from 1995 to 2000, the number of primary investigators in surgery d...

#EA23: EU-HyProtect Study and Predictive Haemodynamic Monitoring New evidence on predictive haemodyanmic monitoring software was presented this week at the Euroanaesthesia Congress in Glasgow.  The EU-HyProtect Registry was created to investigate the occurrence, duration, and seriousness of intraoperative hypotension in patients monitored using Acumen Hypotension Prediction Index software (Acumen HPI software) during elective major non-cardiac surgery. This...

#EA23: Outcome in Patients With Postponed Elective Surgery During COVID-19 The 30-day outcome findings in patients undergoing postponed elective surgery during the COVID-19 pandemic (TRACE II) were presented at a poster session at Euroanaesthesia 2023. The COVID-19 pandemic significantly affected the ability to perform elective surgeries worldwide. To understand the consequences of delayed surgery, the TRACE II study investigates the impact on patients' preopera...

Invited Commentary  May 17, 2023 Long-Term Impact of Trauma in Twins Timothy A. Pritts JAMA Surg. 2023;158(7):746. doi:10.1001/jamasurg.2023.1568 Trauma remains a leading cause of death and disability worldwide. For those who survive a severe traumatic injury, the personal costs are subjectively substantial but may be difficult to objectively quantify. Previous studies attempting to do this have determined that many factors are associated with long-ter...

#EA23: ESAIC Guidelines for Use of Cardiac Biomarkers in Perioperative Risk Evaluation The ESAIC focused guidelines on cardiac biomarkers were presented at Euroanaesthesia 2023 in Glasgow this week. There has been growing interest in utilising cardiac biomarkers in non-cardiac surgery patients. These biomarkers may be used with three separate aims. Firstly, they are used for prognosis, helping to determine how elevated levels of biomarkers affect the risk of spe...

Invited Commentary  May 24, 2023 Local Delivery of Antibiotics—Applications in Cutaneous Surgery and Beyond Amanda R. Sergesketter, Scott T. Hollenbeck JAMA Surg. 2023;158(7):727. doi:10.1001/jamasurg.2023.1215 Across surgical subspecialties, surgical site infections (SSIs) represent a prevalent and costly problem to patients and health care systems, affecting 0.5% to 3.0% of surgical patients and resulting in costs ranging from $3.5 billion to $10 bil...

#EA23 - ESAIC Glasgow Declaration on Anaesthesiology and Intensive Care The European Society of Anaesthesiology and Intensive Care (ESAIC) Glasgow Declaration on Anaesthesiology and Intensive Care (EGD) was officially signed today during the inauguration of the Exhibition at #EA23 the Dear Green Place. This marks a monumental moment in healthcare history.  The European Union (EU) is dedicated to addressing climate change. The European Green Deal initiative ...

Invited Commentary  August 2, 2023 Magic Pen?—An Innovative Adjunct for Intraoperative Identification of Parathyroid Glands Michelle B. Mulder, Quan-Yang Duh JAMA Surg. Published online August 2, 2023. doi:10.1001/jamasurg.2023.3257 DeHoog et al1 introduce the MasSpec Pen (MSPen), a new technology that uses real-time mass spectroscopy for intraoperative parathyroid identification. This device is able to distinguish among parathyroid, thy...

Invited Commentary  April 26, 2023 Optimizing Hemostatic Resuscitation in Trauma—Will Endotyping Be the Key to the “Proper” Ratio? Purvi P. Patel, Matthew J. Martin JAMA Surg. 2023;158(7):736-737. doi:10.1001/jamasurg.2023.0825 “Measure what is measurable, and make measurable what is not so.”1(p301) Galileo Galilei Trauma endotypes (TEs) characterize patients based on dynamic changes in immune and inflammatory biomarkers after injury.2,3 ...

Invited Commentary  August 2, 2023 Should We Care About Hospital Consolidation? Christopher P. Childers, Beverley A. Petrie, Christian de Virgilio JAMA Surg. Published online August 2, 2023. doi:10.1001/jamasurg.2023.3256 Competition among businesses is thought to benefit the consumer. With the recent surge in hospital mergers, there is concern that competition is being stifled and that costs may increase without a concomitant improvement in ...